Digital Quantification of Tumor PD-L1 Predicts Outcome of PD-1-Based Immune Checkpoint Therapy in Metastatic Melanoma.

Front Oncol · 2021 · PMC8491983 · PMID 34621681

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

borderline significanceP=0.051so close (0.05 < p ≤ 0.1)

Survival differences between PD-L1 positive and negative tumors by physician’s quantification showed borderline significance for PFS (P=0.051), and strong significance for OS (P=0.011); Figures 4A, B .

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.